SHEBA MEDICAL CENTER
- Country
- 🇿🇦South Africa
- Ownership
- Private
- Established
- 1948-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.sheba.co.il
Clinical Trials
654
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (417 trials with phase data)• Click on a phase to view related trials
Trans-Cervical and Trans-abdominal Ultrasound for Monitoring Esophageal Thickness in Eosinophilic Esophagitis
- Conditions
- Eosinophilic Esophagitis (EoE)
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT07057986
Paromomycin or Metronidazole for Symptomatic Dientamoeba Fragilis in Adults
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT06907498
- Locations
- 🇮🇱
Sheba medical center, Ramat Gan, Israel
ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study
- Conditions
- Alk-positive Non-Small Cell Lung CancerALK-inhibitor Treated
- First Posted Date
- 2025-02-26
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06846736
- Locations
- 🇮🇱
Sheba Medical Center, Ramat Gan, Israel
Prospective, Randomized Trial Comparing Soft and Firm Ureteral Stents
- Conditions
- Urolithiasis
- First Posted Date
- 2024-12-27
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT06749652
- Locations
- 🇮🇱
Sheba Medical Center, Ramat Gan, Hamerkaz, Israel
The Utility of Hand-held Ultrasound Devices to Detect Bowel Wall Inflammatory Activity in Crohn's Disease
- Conditions
- Crohn Disease (CD)
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT06686589
- Prev
- 1
- 2
- 3
- 4
- 5
- 131
- Next
News
Israeli Researchers Develop Bioengineered Skin Graft That Accelerates Burn Healing by 50%
Researchers from Tel Aviv University and Sheba Medical Center have developed a bioengineered skin graft using patients' own cells that heals burns in half the time of standard treatments.
Mentaily Secures $3M Seed Funding for AI-Powered Mental Health Diagnostic Platform LIV
Mentaily, founded in 2024, raised $3 million in seed funding to advance its AI-powered mental health assessment platform LIV, which simulates clinical psychiatric intake sessions with high diagnostic accuracy.
Tethis and Sheba Medical Center Partner on AI-Powered Liquid Biopsy for Early Rectal Cancer Detection
Tethis S.p.A. and Sheba Medical Center have launched a research collaboration to evaluate circulating tumor cells in rectal cancer patients using Tethis' proprietary See.d® technology.
Inspira Technologies Enhances HYLA Blood Sensor with AI-Powered Oxygenation Monitoring
Inspira Technologies has integrated a next-generation oxygenation indicator into its HYLA blood sensor, enabling continuous monitoring of tissue oxygenation without blood draws.
New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis
Ursodeoxycholic acid (UDCA), while groundbreaking, leaves up to 40% of Primary Biliary Cholangitis patients with inadequate response, highlighting the need for additional treatment options.
Israeli Healthtech Innovation Drives Global Healthcare Solutions
Israel's healthtech sector is thriving, ranking third globally in tech company density and driving innovation in AI-driven healthcare and precision medicine.
CBD Shows Promise in Curbing SARS-CoV-2 Replication, Clinical Trials Needed
Early research suggests CBD may help curb SARS-CoV-2 replication in infected cells, warranting further investigation through rigorous clinical trials.